<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Korean J Pain</journal-id><journal-id journal-id-type="publisher-id">KJP</journal-id><journal-title-group><journal-title>The Korean Journal of Pain</journal-title></journal-title-group><issn pub-type="ppub">2005-9159</issn><issn pub-type="epub">2093-0569</issn><publisher><publisher-name>The Korean Pain Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21935491</article-id><article-id pub-id-type="pmc">3172326</article-id><article-id pub-id-type="doi">10.3344/kjp.2011.24.3.137</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Preemptive Use of Ketamine on Post Operative Pain of Appendectomy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Behdad</surname><given-names>Akbar</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hosseinpour</surname><given-names>Mehrdad</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib><contrib contrib-type="author"><name><surname>Khorasani</surname><given-names>Parastoo</given-names></name><xref ref-type="aff" rid="A1"></xref></contrib></contrib-group><aff id="A1">Medical University of Isfahan, Trauma Research Center, Kashan University of Medical Sciences, Kashan, Iran.</aff><author-notes><corresp>Correspondence to: Mehrdad Hosseinpour. Trauma Research Center, Kashan University of Medical Sciences, Gotbe Ravandi Blvd., Kashan, Iran. Tel: +983116255368, Fax: +983116255368, <email>meh_hosseinpour@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>06</day><month>9</month><year>2011</year></pub-date><volume>24</volume><issue>3</issue><fpage>137</fpage><lpage>140</lpage><history><date date-type="received"><day>19</day><month>7</month><year>2011</year></date><date date-type="rev-recd"><day>05</day><month>8</month><year>2011</year></date><date date-type="accepted"><day>08</day><month>8</month><year>2011</year></date></history><permissions><copyright-statement>Copyright © The Korean Pain Society, 2011</copyright-statement><copyright-year>2011</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title><offsets xml_i="3061" xml_f="3071" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3082" xml_f="3375" txt_i="22" txt_f="315">Although early reviews of clinical findings were mostly negative, there is still a widespread belief for the efficacy of preemptive analgesia among clinicians. In this study, we evaluated whether the preemptive use of ketamine decreases post operative pain in patients undergoing appendectomy.</offsets></p></sec><sec><title><offsets xml_i="3397" xml_f="3404" txt_i="317" txt_f="324">Methods</offsets></title><p><offsets xml_i="3415" xml_f="3941" txt_i="325" txt_f="851">In double-blind, randomized clinical trials, 80 adult male patients undergoing an operation for acute appendicitis were studied. Patients were randomly assigned to two groups. In the operating room, patients in the ketamine group received 0.5 mg/kg of ketamine IV 10 minutes before the surgical incision. In the control group, 0.5 mg/kg of normal saline was injected. The pain intensity was assessed at time 0 (immediately after arousal) and 4, 12, and 24 hours postoperatively using the 10 points visual analogue scale (VAS).</offsets></p></sec><sec><title><offsets xml_i="3963" xml_f="3970" txt_i="853" txt_f="860">Results</offsets></title><p><offsets xml_i="3981" xml_f="4296" txt_i="861" txt_f="1176">Eighty patients (40 for both groups) were enrolled in this study. For all of the evaluated times, the VAS score was significantly lower in the ketamine group compared to the control. The interval time for the first analgesic request was 23.1 ± 6.7 minutes for the case group and 18.1 ± 7.3 minutes for the control (</offsets><italic><offsets xml_i="4304" xml_f="4305" txt_i="1176" txt_f="1177">P</offsets></italic><offsets xml_i="4314" xml_f="4468" txt_i="1177" txt_f="1331"> = 0.02). The total number of pethidine injections in the first 24 hours postoperatively was 0.6 ± 0.6 for the case group and 2.0 ± 0.8 for the controls (</offsets><italic><offsets xml_i="4476" xml_f="4477" txt_i="1331" txt_f="1332">P</offsets></italic><offsets xml_i="4486" xml_f="4548" txt_i="1332" txt_f="1394"> = 0.032). There were no drug side effects for the case group.</offsets></p></sec><sec><title><offsets xml_i="4570" xml_f="4581" txt_i="1396" txt_f="1407">Conclusions</offsets></title><p><offsets xml_i="4592" xml_f="4702" txt_i="1408" txt_f="1518">A low dose of intravenously administered ketamine had a preemptive effect in reducing pain after appendectomy.</offsets></p></sec></abstract><kwd-group><kwd>appendectomy</kwd><kwd>ketamine</kwd><kwd>pre-emptive analgesia</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title><offsets xml_i="4878" xml_f="4890" txt_i="1527" txt_f="1539">INTRODUCTION</offsets></title><p><offsets xml_i="4901" xml_f="5035" txt_i="1540" txt_f="1674">The concept of preemptive analgesia to reduce the magnitude and duration of postoperative pain was first introduced in 1983 by Woolf [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="5066" xml_f="5067" txt_i="1674" txt_f="1675">1</offsets></xref><offsets xml_i="5074" xml_f="5423" txt_i="1675" txt_f="2024">] who showed evidence for a central component of post-injury pain hypersensitivity in experimental studies. Subsequently, several experimented studies demonstrated that various anti-nociceptive techniques applied before injuries were more effective in reducing the post-injury central sensitization phenomena compared to administration after injury.</offsets></p><p><offsets xml_i="5430" xml_f="5496" txt_i="2025" txt_f="2091">Although early reviews of clinical findings were mostly negative [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="5527" xml_f="5528" txt_i="2091" txt_f="2092">2</offsets></xref><offsets xml_i="5535" xml_f="5536" txt_i="2092" txt_f="2093">,</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="5567" xml_f="5568" txt_i="2093" txt_f="2094">3</offsets></xref><offsets xml_i="5575" xml_f="5669" txt_i="2094" txt_f="2188">] there is still a widespread belief in the efficacy of preemptive analgesia among clinicians.</offsets></p><p><offsets xml_i="5676" xml_f="5818" txt_i="2189" txt_f="2331">Since ketamine is a well known general anesthetic and short acting intra operative analgesic that acts on nicotinic and muscarinic receptors [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="5849" xml_f="5850" txt_i="2331" txt_f="2332">4</offsets></xref><offsets xml_i="5857" xml_f="5991" txt_i="2332" txt_f="2466">], in this study, we evaluated whether preemptive use of ketamine decreases post operative pain in patients undergoing appendectomies.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="6042" xml_f="6063" txt_i="2468" txt_f="2489">MATERIALS AND METHODS</offsets></title><p><offsets xml_i="6074" xml_f="6665" txt_i="2490" txt_f="3081">In a double blind, randomized clinical trial, 80 adult male patients who were undergoing an operation for acute appendicitis were included in this study. The study was approved by the local ethical committee. After obtaining informed written consent, patients were randomly assigned to two groups (ketamine and control). Patients were excluded if they had a history of cardiovascular disease, hypertension (as evaluated by cardiovascular internist), increased intracranial pressure, epilepsy, cerebrovascular accident (as evaluated by one neurologist), psychiatric disorders, and drug abuse.</offsets></p><p><offsets xml_i="6672" xml_f="7170" txt_i="3082" txt_f="3580">To examine the preemptive effect of ketamine, a randomized controlled trial was done from April 2010 to March 2011. A double - blind technique was used in which the surgeon and research physician who was responsible for data collection were unaware of the allocation of the study participants. The authors randomly assigned patients into a case group and a control group (patients with an even identical number were assigned to the ketamine group and those with an odd number to the control group).</offsets></p><p><offsets xml_i="7177" xml_f="7740" txt_i="3581" txt_f="4144">In operating room, patients in ketamine group, received 0.5 mg/kg of ketamine IV, 10 minutes before surgical incision by specialist nurse. In the control group, 0.5 mg/kg of normal saline was injected. All patients were premedicated with midazolam 0.05 mg/kg IV before anesthesia to avoid the probable side effects of ketamine. Patients were operated on under general anesthesia with a Mcburney incision and the appendectomy was done. General anesthesia was induced with thiopental (6 mg/kg) and atracurium (0.5 mg/kg). For maintenance, isoflurane (0.5-1%), 50% N</offsets><sub><offsets xml_i="7745" xml_f="7746" txt_i="4144" txt_f="4145">2</offsets></sub><offsets xml_i="7752" xml_f="7764" txt_i="4145" txt_f="4157">O, and 50% O</offsets><sub><offsets xml_i="7769" xml_f="7770" txt_i="4157" txt_f="4158">2</offsets></sub><offsets xml_i="7776" xml_f="7787" txt_i="4158" txt_f="4169"> were used.</offsets></p><p><offsets xml_i="7794" xml_f="8255" txt_i="4170" txt_f="4631">Postoperatively, if patients asked for analgesia, 1 mg/kg of pethidine was administered intravenously for adequate analgesia. Pain intensity was assessed at time 0 (immediately after arousal) and 4, 12, and 24 hours postoperatively by a physician who was unaware of the allocation of the study's participants. Time 0 was the time of complete consciousness. Pain was scored using the 10 point visual analogue scale (VAS; 0 = no pain, 10 = worst pain imaginable).</offsets></p><p><offsets xml_i="8262" xml_f="8789" txt_i="4632" txt_f="5159">Other than the VAS score, the interval time for the first request of analgesia and the number of times pethidine was injected in the first 24 hours was recorded. Patients also were checked for side effects such as delusions and delirium. Data were presented as the mean ± SD for quantitative variables. The Mann Whitney test was used to compare VAS scores, interval time of the first request of analgesia, and total amount of analgesia in the first 24 hours. Statistical analysis was done with SPSS 11.5 (Chicago, SPSS Inc). A </offsets><italic><offsets xml_i="8797" xml_f="8798" txt_i="5159" txt_f="5160">P</offsets></italic><offsets xml_i="8807" xml_f="8864" txt_i="5160" txt_f="5217"> less than 0.05 was considered statistically significant.</offsets></p></sec><sec sec-type="results"><title><offsets xml_i="8905" xml_f="8912" txt_i="5219" txt_f="5226">RESULTS</offsets></title><p><offsets xml_i="8923" xml_f="9203" txt_i="5227" txt_f="5507">Eighty patients (40 in the ketamine group and 40 in the control group) were enrolled in this study. The mean age of the patients was 25.3 ± 11.4 years (rang 16-24 years). The duration of the surgery was 33.2 ± 10.3 minutes. The duration of the anesthesia was 47.2 ± 11.2 minutes. </offsets><xref ref-type="table" rid="T1"><offsets xml_i="9235" xml_f="9242" txt_i="5507" txt_f="5514">Table 1</offsets></xref><offsets xml_i="9249" xml_f="9413" txt_i="5514" txt_f="5678"> shows the comparison of the basic data in the two groups. There were no significant differences in these variables between the groups. VAS scores are presented in </offsets><xref ref-type="table" rid="T2"><offsets xml_i="9445" xml_f="9452" txt_i="5678" txt_f="5685">Table 2</offsets></xref><offsets xml_i="9459" xml_f="9725" txt_i="5685" txt_f="5951">. For all of the evaluated times, the VAS score was significantly lower in the ketamine group than that of the control group. The interval time for the first analgesic request was 23.1 ± 6.7 minutes in the ketamine group and 18.1 ± 7.3 minutes in the control group (</offsets><italic><offsets xml_i="9733" xml_f="9734" txt_i="5951" txt_f="5952">P</offsets></italic><offsets xml_i="9743" xml_f="9986" txt_i="5952" txt_f="6195"> = 0.02). In the ketamine group, 42.5% of the patients did not need analgesics postoperatively. The total number of pethidine injections in first 24 hours postoperatively was 0.6 ± 0.6 in the ketamine group and 2.0 ± 0.8 in the control group (</offsets><italic><offsets xml_i="9994" xml_f="9995" txt_i="6195" txt_f="6196">P</offsets></italic><offsets xml_i="10004" xml_f="10069" txt_i="6196" txt_f="6261"> = 0.032). There were no drug side effects in the ketamine group.</offsets></p></sec><sec sec-type="discussion"><title><offsets xml_i="10113" xml_f="10123" txt_i="6263" txt_f="6273">DISCUSSION</offsets></title><p><offsets xml_i="10134" xml_f="10644" txt_i="6274" txt_f="6784">Surgical procedures almost invariably cause tissue damage resulting in pain. The impact of inadequate pain relief is well known and it can result in delayed mobilization and related complications as well as psychological distress and anxiety. The main finding of this study shows that preemptive intravenous low dose ketamine decreased postoperative pain in patients undergoing appendectomies. Ketamine is a well known general anesthetics and short acting intraoperative analgesic in use for almost 4 decades [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="10675" xml_f="10676" txt_i="6784" txt_f="6785">5</offsets></xref><offsets xml_i="10683" xml_f="10818" txt_i="6785" txt_f="6920">]. It is well-known that high doses of ketamine act as an intravenous anesthetic, and low doses of ketamine act as an analgesic agent [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="10849" xml_f="10850" txt_i="6920" txt_f="6921">6</offsets></xref><offsets xml_i="10857" xml_f="10858" txt_i="6921" txt_f="6922">,</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="10889" xml_f="10890" txt_i="6922" txt_f="6923">7</offsets></xref><offsets xml_i="10897" xml_f="10899" txt_i="6923" txt_f="6925">].</offsets></p><p><offsets xml_i="10906" xml_f="10999" txt_i="6926" txt_f="7019">Some studies have reported the recent discovery of the N-methyl-D-aspartate (NMDA) receptor [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="11030" xml_f="11031" txt_i="7019" txt_f="7020">8</offsets></xref><offsets xml_i="11038" xml_f="11122" txt_i="7020" txt_f="7104">], which seems to play a role in pain transmission, and according to other studies [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="11153" xml_f="11154" txt_i="7104" txt_f="7105">9</offsets></xref><offsets xml_i="11161" xml_f="11280" txt_i="7105" txt_f="7224">], ketamine binds to these receptors with a nonselective antagonism reducing hyperalgesia. Ketamine acts on nicotinic [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="11312" xml_f="11314" txt_i="7224" txt_f="7226">10</offsets></xref><offsets xml_i="11321" xml_f="11322" txt_i="7226" txt_f="7227">,</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="11354" xml_f="11356" txt_i="7227" txt_f="7229">11</offsets></xref><offsets xml_i="11363" xml_f="11545" txt_i="7229" txt_f="7411">] and muscarinic receptors; it blocks sodium channels in the peripheral and human central nervous system and interacts with opioid receptors, µ, δ, and κ, and with calcium channels [</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="11577" xml_f="11579" txt_i="7411" txt_f="7413">12</offsets></xref><offsets xml_i="11586" xml_f="11713" txt_i="7413" txt_f="7540">]. Ketamine also acts as a non-competitive antagonist at the phencyclidine receptor site in the NMDA receptor complex channel [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="11745" xml_f="11747" txt_i="7540" txt_f="7542">13</offsets></xref><offsets xml_i="11754" xml_f="11755" txt_i="7542" txt_f="7543">,</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="11787" xml_f="11789" txt_i="7543" txt_f="7545">14</offsets></xref><offsets xml_i="11796" xml_f="11947" txt_i="7545" txt_f="7696">]. The role of NMDA receptors in the processing of nociceptive input is antagonized by low-doses of ketamine, which induces a noncompetitive blockade [</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="11979" xml_f="11981" txt_i="7696" txt_f="7698">15</offsets></xref><offsets xml_i="11988" xml_f="11989" txt_i="7698" txt_f="7699">-</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="12021" xml_f="12023" txt_i="7699" txt_f="7701">18</offsets></xref><offsets xml_i="12030" xml_f="12289" txt_i="7701" txt_f="7960">]; this raises the possibility that ketamine can become "trapped" in the receptor channel until the channel reopens after agonist activation. Many clinical trials have been done to evaluate ketamine administration for postoperative pain management; the oral [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="12321" xml_f="12323" txt_i="7960" txt_f="7962">19</offsets></xref><offsets xml_i="12330" xml_f="12341" txt_i="7962" txt_f="7973">], rectal [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="12373" xml_f="12375" txt_i="7973" txt_f="7975">20</offsets></xref><offsets xml_i="12382" xml_f="12401" txt_i="7975" txt_f="7994">], and intranasal [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="12433" xml_f="12435" txt_i="7994" txt_f="7996">21</offsets></xref><offsets xml_i="12442" xml_f="12551" txt_i="7996" txt_f="8105">] routes of administration for ketamine have been evaluated to provide premedication for general anesthesia [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="12583" xml_f="12585" txt_i="8105" txt_f="8107">19</offsets></xref><offsets xml_i="12592" xml_f="12607" txt_i="8107" txt_f="8122">] or sedation [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="12639" xml_f="12641" txt_i="8122" txt_f="8124">22</offsets></xref><offsets xml_i="12648" xml_f="12788" txt_i="8124" txt_f="8264">], but the analgesic effects of these routes of administration during the postoperative period have not been well determined. Some authors [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="12820" xml_f="12822" txt_i="8264" txt_f="8266">21</offsets></xref><offsets xml_i="12829" xml_f="12830" txt_i="8266" txt_f="8267">,</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="12862" xml_f="12864" txt_i="8267" txt_f="8269">22</offsets></xref><offsets xml_i="12871" xml_f="13021" txt_i="8269" txt_f="8419">] evaluated the subcutaneous administration of this general intravenous anesthetic; it has been shown that low doses (1.7 µg/kg per min) subcutaneous.</offsets></p><p><offsets xml_i="13028" xml_f="13321" txt_i="8420" txt_f="8713">Ketamine administered after major abdominal surgery did not produce adverse effects and provided postoperative analgesia equivalent to a subcutaneous morphine infusion of 2 mg/h. The rationale for preemptive analgesia in the management of postoperative pain has been reported by many authors [</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="13353" xml_f="13355" txt_i="8713" txt_f="8715">23</offsets></xref><offsets xml_i="13362" xml_f="13363" txt_i="8715" txt_f="8716">,</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="13395" xml_f="13397" txt_i="8716" txt_f="8718">24</offsets></xref><offsets xml_i="13404" xml_f="14654" txt_i="8718" txt_f="9968">]; since ketamine is an NMDA-receptor (involved in the mechanisms of hyperalgesia) antagonist, it is hypothesized to prevent or reverse central sensitization and thus, to reduce postoperative pain. In carrying out our study and analyzing the literature, we had to answer some clinical questions, and the first was "Can ketamine be administered as a postoperative analgesic?" According to the literature and to the results of this study, we can answer this question as "yes." Preemptive ketamine for the control of postoperative pain is currently in use even if its use is controversial; it use has consensus and dissension; different doses and routes of administration (intravenous or epidural) are suggested, as well as different adequate perioperative times of administration (at the induction of anesthesia or at the awakening). In this study, VAS measurements showed that ketamine provided good analgesia. Moreover, some patients who received preemptive ketamine did not require any postoperative analgesia within the first 24 hours of the operation. In our investigation, there was a statistical difference between the two groups in the total dose of analgesic consumption postoperatively and in the time interval to request the first analgesic.</offsets></p><p><offsets xml_i="14661" xml_f="14788" txt_i="9969" txt_f="10096">In conclusion, a low dose of intravenously administered ketamine had a preemptive effect in reducing pain after appendectomies.</offsets></p></sec></body><back><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name><name><surname>Chong</surname><given-names>MS</given-names></name></person-group><article-title>Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization</article-title><source>Anesth Analg</source><year>1993</year><volume>77</volume><fpage>362</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">8346839</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebrun</surname><given-names>T</given-names></name><name><surname>Van Elstraete</surname><given-names>AC</given-names></name><name><surname>Sandefo</surname><given-names>I</given-names></name><name><surname>Polin</surname><given-names>B</given-names></name><name><surname>Pierre-Louis</surname><given-names>L</given-names></name></person-group><article-title>Lack of a pre-emptive effect of low-dose ketamine on postoperative pain following oral surgery</article-title><source>Can J Anaesth</source><year>2006</year><volume>53</volume><fpage>146</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">16434754</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>F</given-names></name><name><surname>Libier</surname><given-names>M</given-names></name><name><surname>Oszustowicz</surname><given-names>T</given-names></name><name><surname>Lefebvre</surname><given-names>D</given-names></name><name><surname>Beal</surname><given-names>J</given-names></name><name><surname>Meynadier</surname><given-names>J</given-names></name></person-group><article-title>Preoperative small-dose ketamine has no preemptive analgesic effect in patients undergoing total mastectomy</article-title><source>Anesth Analg</source><year>1999</year><volume>89</volume><fpage>444</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">10439763</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Stanbury</surname><given-names>L</given-names></name></person-group><article-title>A review of postoperative pain management and the challenges</article-title><source>Curr Anaesth Crit Care</source><year>2009</year><volume>20</volume><fpage>188</fpage><lpage>194</lpage></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>I</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name><name><surname>Kang</surname><given-names>MS</given-names></name><name><surname>Suh</surname><given-names>MK</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name></person-group><article-title>Ketamine infusion therapy in a patient of posttraumatic syringomyelia</article-title><source>Korean J Pain</source><year>2008</year><volume>21</volume><fpage>248</fpage><lpage>251</lpage></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>JH</given-names></name><name><surname>Koo</surname><given-names>MS</given-names></name><name><surname>Nahm</surname><given-names>FS</given-names></name><name><surname>Shin</surname><given-names>HY</given-names></name><name><surname>Choi</surname><given-names>YM</given-names></name><name><surname>Jo</surname><given-names>JY</given-names></name><etal></etal></person-group><article-title>Pain management via a subcutaneous infusion of ketamine in a patient with complex regional pain syndrome: a case report</article-title><source>Korean J Pain</source><year>2007</year><volume>20</volume><fpage>190</fpage><lpage>194</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickenson</surname><given-names>AH</given-names></name><name><surname>Sullivan</surname><given-names>AF</given-names></name></person-group><article-title>Combination therapy in analgesia; seeking synergy</article-title><source>Curr Opin Anaesthesiol</source><year>1993</year><volume>6</volume><fpage>861</fpage><lpage>865</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>AC</given-names></name><name><surname>Fagg</surname><given-names>GE</given-names></name></person-group><article-title>Neurobiology. Taking apart NMDA receptors</article-title><source>Nature</source><year>1987</year><volume>329</volume><fpage>395</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">2443852</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traynelis</surname><given-names>SF</given-names></name><name><surname>Wollmuth</surname><given-names>LP</given-names></name><name><surname>McBain</surname><given-names>CJ</given-names></name><name><surname>Menniti</surname><given-names>FS</given-names></name><name><surname>Vance</surname><given-names>KM</given-names></name><name><surname>Ogden</surname><given-names>KK</given-names></name><etal></etal></person-group><article-title>Glutamate receptor ion channels: structure, regulation, and function</article-title><source>Pharmacol Rev</source><year>2010</year><volume>62</volume><fpage>405</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">20716669</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheller</surname><given-names>M</given-names></name><name><surname>Bufler</surname><given-names>J</given-names></name><name><surname>Hertle</surname><given-names>I</given-names></name><name><surname>Schneck</surname><given-names>HJ</given-names></name><name><surname>Franke</surname><given-names>C</given-names></name><name><surname>Kochs</surname><given-names>E</given-names></name></person-group><article-title>Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state</article-title><source>Anesth Analg</source><year>1996</year><volume>83</volume><fpage>830</fpage><lpage>836</lpage><pub-id pub-id-type="pmid">8831330</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hustveit</surname><given-names>O</given-names></name><name><surname>Maurset</surname><given-names>A</given-names></name><name><surname>Oye</surname><given-names>I</given-names></name></person-group><article-title>Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors</article-title><source>Pharmacol Toxicol</source><year>1995</year><volume>77</volume><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">8835358</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Lambert</surname><given-names>DG</given-names></name></person-group><article-title>Ketamine: its mechanism(s) of action and unusual clinical uses</article-title><source>Br J Anaesth</source><year>1996</year><volume>77</volume><fpage>441</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">8942324</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willetts</surname><given-names>J</given-names></name><name><surname>Balster</surname><given-names>RL</given-names></name><name><surname>Leander</surname><given-names>JD</given-names></name></person-group><article-title>The behavioral pharmacology of NMDA receptor antagonists</article-title><source>Trends Pharmacol Sci</source><year>1990</year><volume>11</volume><fpage>423</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">2147794</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamura</surname><given-names>T</given-names></name><name><surname>Harada</surname><given-names>K</given-names></name><name><surname>Okamura</surname><given-names>A</given-names></name><name><surname>Kemmotsu</surname><given-names>O</given-names></name></person-group><article-title>Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor?</article-title><source>Anesthesiology</source><year>1990</year><volume>72</volume><fpage>704</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">1969718</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilkjaer</surname><given-names>S</given-names></name><name><surname>Petersen</surname><given-names>KL</given-names></name><name><surname>Brennum</surname><given-names>J</given-names></name><name><surname>Wernberg</surname><given-names>M</given-names></name><name><surname>Dahl</surname><given-names>JB</given-names></name></person-group><article-title>Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans</article-title><source>Br J Anaesth</source><year>1996</year><volume>76</volume><fpage>829</fpage><lpage>834</lpage><pub-id pub-id-type="pmid">8679358</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickenson</surname><given-names>AH</given-names></name></person-group><article-title>Spinal cord pharmacology of pain</article-title><source>Br J Anaesth</source><year>1995</year><volume>75</volume><fpage>193</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">7577253</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogawski</surname><given-names>MA</given-names></name></person-group><article-title>Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines</article-title><source>Trends Pharmacol Sci</source><year>1993</year><volume>14</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">7504360</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orser</surname><given-names>BA</given-names></name><name><surname>Pennefather</surname><given-names>PS</given-names></name><name><surname>MacDonald</surname><given-names>JF</given-names></name></person-group><article-title>Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors</article-title><source>Anesthesiology</source><year>1997</year><volume>86</volume><fpage>903</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">9105235</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alderson</surname><given-names>PJ</given-names></name><name><surname>Lerman</surname><given-names>J</given-names></name></person-group><article-title>Oral premedication for paediatric ambulatory anaesthesia: a comparison of midazolam and ketamine</article-title><source>Can J Anaesth</source><year>1994</year><volume>41</volume><fpage>221</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">8187256</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cioacă</surname><given-names>R</given-names></name><name><surname>Canavea</surname><given-names>I</given-names></name></person-group><article-title>Oral transmucosal ketamine: an effective premedication in children</article-title><source>Paediatr Anaesth</source><year>1996</year><volume>6</volume><fpage>361</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">8880815</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weksler</surname><given-names>N</given-names></name><name><surname>Ovadia</surname><given-names>L</given-names></name><name><surname>Muati</surname><given-names>G</given-names></name><name><surname>Stav</surname><given-names>A</given-names></name></person-group><article-title>Nasal ketamine for paediatric premedication</article-title><source>Can J Anaesth</source><year>1993</year><volume>40</volume><fpage>119</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">8443849</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonzo-Echeverri</surname><given-names>EC</given-names></name><name><surname>Berg</surname><given-names>JH</given-names></name><name><surname>Wild</surname><given-names>TW</given-names></name><name><surname>Glass</surname><given-names>NL</given-names></name></person-group><article-title>Oral ketamine for pediatric outpatient dental surgery sedation</article-title><source>Pediatr Dent</source><year>1993</year><volume>15</volume><fpage>182</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">8378155</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Kavanagh</surname><given-names>BP</given-names></name><name><surname>Sandler</surname><given-names>AN</given-names></name><name><surname>Nierenberg</surname><given-names>H</given-names></name><name><surname>Boylan</surname><given-names>JF</given-names></name><name><surname>Friedlander</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Preemptive analgesia. Clinical evidence of neuroplasticity contributing to postoperative pain</article-title><source>Anesthesiology</source><year>1992</year><volume>77</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">1519781</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coderre</surname><given-names>TJ</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Vaccarino</surname><given-names>AL</given-names></name><name><surname>Melzack</surname><given-names>R</given-names></name></person-group><article-title>Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence</article-title><source>Pain</source><year>1993</year><volume>52</volume><fpage>259</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">7681556</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Basic Variables of Patients</p></caption><graphic xlink:href="kjpain-24-137-i001"></graphic><table-wrap-foot><fn><p>Values are mean ± SD.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Changes of VAS Score During 24 Hours after Appendectomy</p></caption><graphic xlink:href="kjpain-24-137-i002"></graphic><table-wrap-foot><fn><p>Values are mean ± SD.</p></fn></table-wrap-foot></table-wrap></floats-group></article>